menu
    • menu

    Company profile for R3 Vascular

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    R3 Vascular Inc. is an early-stage medical device company that has created a novel technology platform for the development and manufacturing of fully bioresorbable vascular scaffolds (BVS). The company’s products are designed to afford the strength of metallic stents to assist the artery during the remodeling process following an interventional procedure, without leaving behind a permanent implant with inherent clinical limi...
    R3 Vascular Inc. is an early-stage medical device company that has created a novel technology platform for the development and manufacturing of fully bioresorbable vascular scaffolds (BVS). The company’s products are designed to afford the strength of metallic stents to assist the artery during the remodeling process following an interventional procedure, without leaving behind a permanent implant with inherent clinical limitations. R3 Vascular is developing a world class bioresorbable scaffold technology with a Sirolimus coating - for the treatment of Peripheral Arterial Disease below the knee (BTK).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    R3 VascularUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1145 Terra Bella Ave Mountain View, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.r3vascular.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    R3 Vascular Announces 1st Patient Treated in ELITE-BTK Trial
    R3 Vascular Announces 1st Patient Treated in ELITE-BTK Trial

    22 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/22/3065281/0/en/R3-Vascular-Announces-First-Patient-Treated-in-ELITE-BTK-Pivotal-Trial-for-Below-the-Knee-PAD-Using-MAGNITUDE-Drug-Eluting-Bioresorbable-Scaffold.html

    GLOBENEWSWIRE
    22 Apr 2025
    Share Share
    FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial
    FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial

    04 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/04/2973818/0/en/FDA-Grants-R3-Vascular-IDE-Approval-for-ELITE-BTK-Pivotal-Trial-of-its-MAGNITUDE-Drug-Eluting-Next-Generation-Bioresorbable-Scaffold-for-Below-the-Knee-Peripheral-Arterial-Disease.html

    GLOBENEWSWIRE
    04 Nov 2024
    Share Share
    R3 Vascular Appoints Josh Smale As VP Of Clinical And Scientific Affairs
    R3 Vascular Appoints Josh Smale As VP Of Clinical And Scientific Affairs

    09 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/07/09/2910677/0/en/R3-Vascular-Appoints-Josh-Smale-as-its-Vice-President-of-Global-Clinical-and-Scientific-Affairs.html

    GLOBENEWSWIRE
    09 Jul 2024
    Share Share
    R3 Vascular $87M Series B, New CEO Christopher Owens
    R3 Vascular $87M Series B, New CEO Christopher Owens

    09 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/09/2879009/0/en/R3-Vascular-Announces-87-Million-in-Series-B-Financing-and-Appoints-Christopher-M-Owens-as-new-President-and-CEO.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search